Compound Evidence File
#EC-2026-0986
DHB (1-Test Cyp)
Filed under Injectable Oils. The bureau holds 93 laboratory returns for this compound from 33 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
33 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 7 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 4 | 10.0 | 9.9 | 10.0 | 27 Dec 2025 | 4 Jul 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 10.0 | 9.9 | 10.0 | 2 Nov 2025 | 10 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 3 | 10.0 | 9.9 | 10.0 | 6 Jun 2026 | 10 Jul 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 10.0 | 10.0 | 10.0 | 18 Jan 2026 | 15 Mar 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 2 | 10.0 | 10.0 | 10.0 | 10 Mar 2026 | 12 Jul 2026 |
| Mai PeptideCASE #VI-2026-0769 | X | 1 | 10.0 | 10.0 | 10.0 | 11 Jun 2025 | 11 Jun 2025 |
| HomopeptideCASE #VI-2026-0760 | A | 4 | 9.9 | 9.9 | 10.0 | 21 May 2026 | 21 May 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 9.9 | 9.9 | 10.0 | 1 Mar 2026 | 2 May 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 9.9 | 9.9 | 10.0 | 9 Jan 2026 | 15 Jun 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 4 | 9.9 | 9.9 | 10.0 | 24 Mar 2026 | 18 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 9.9 | 9.9 | 10.0 | 14 May 2026 | 10 Jul 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 4 | 9.9 | 9.9 | 10.0 | 7 Nov 2025 | 19 Jun 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 3 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 6 May 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 9.9 | 9.9 | 10.0 | 8 Mar 2026 | 7 Jun 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 9.9 | 9.9 | 10.0 | 19 Jun 2026 | 13 Jul 2026 |
| Laicuinuo LCNCASE #VI-2026-0223 | X | 1 | 9.2 | 9.2 | 9.2 | 20 Jun 2025 | 20 Jun 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 2 | 9.1 | 8.9 | 9.2 | 24 May 2026 | 24 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 5 | 8.5 | 7.5 | 10.0 | 21 May 2026 | 21 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 3 | 8.5 | 7.7 | 9.9 | 21 May 2026 | 21 May 2026 |
| Yongkang Nuoao Trading CoCASE #VI-2026-0646 | X | 1 | 8.2 | 8.2 | 8.2 | 13 Jun 2025 | 13 Jun 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 6 | 8.0 | 7.5 | 8.8 | 24 May 2026 | 24 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 5 | 7.7 | 6.5 | 9.4 | 24 May 2026 | 24 May 2026 |
| EHZ PeptidesCASE #VI-2026-0296 | C | 2 | 6.5 | 5.9 | 7.1 | 9 Jun 2025 | 26 Jan 2026 |
| Shanxi Qianyecao Biotech QYCCASE #VI-2026-0189 | X | 3 | 6.4 | 5.1 | 7.6 | 14 Jan 2025 | 21 May 2026 |
| HXNetCASE #VI-2026-0061 | X | 1 | 6.4 | 6.4 | 6.4 | 25 Apr 2025 | 25 Apr 2025 |
| Rayshine Peptide BiochemicalsCASE #VI-2026-0545 | X | 1 | 6.1 | 6.1 | 6.1 | 27 Feb 2025 | 27 Feb 2025 |
| Hangzhou Mandy BiotechnologyCASE #VI-2026-0695 | X | 1 | 5.5 | 5.5 | 5.5 | 24 Apr 2025 | 24 Apr 2025 |
| Zztai PeptideCASE #VI-2026-0192 | C | 2 | 5.4 | 4.6 | 6.2 | 3 Jul 2025 | 17 May 2026 |
| Zhejiang Yichenkang BiotechnologyCASE #VI-2026-0269 | X | 2 | 5.3 | 4.0 | 6.6 | 2 Apr 2025 | 19 Jan 2026 |
| Shanghai Leader Peptide BiotechnologyCASE #VI-2026-0558 | X | 1 | 4.9 | 4.9 | 4.9 | 13 Jun 2025 | 13 Jun 2025 |
| PepLab SolutionsCASE #VI-2026-0431 | X | 1 | 2.3 | 2.3 | 2.3 | 2 Apr 2025 | 2 Apr 2025 |
| Peptides For SaleCASE #VI-2026-0614 | X | 2 | 1.8 | 1.4 | 2.3 | 6 May 2025 | 23 May 2026 |
Open any subject to view the batch-level evidence for DHB (1-Test Cyp) alone.